Lung transplantation in patients with cystic fibrosis and Mycobacterium abscessus infection

Journal of Cystic Fibrosis

Volumn 9, Issue 4, 2010, Pages 272-276

  Gilljam, Marita ^a   Scherstén, Henrik ^a   Silverborn, Martin ^a   Jönsson, Bodil ^a   Ericsson Hollsing, Annika ^b  

^a SAHLGRENSKA UNIVERSITY HOSPITAL   (Sweden)

^b UPPSALA UNIVERSITY HOSPITAL   (Sweden)

Author keywords

Abscess; Complication; Cystic fibrosis; Lung transplantation; Mycobacterium

Indexed keywords

AMIKACIN; AMPHOTERICIN B; ANTIBIOTIC AGENT; ANTIFUNGAL AGENT; AZATHIOPRINE; AZITHROMYCIN; CASPOFUNGIN; CEFTAZIDIME; CLARITHROMYCIN; COTRIMOXAZOLE; CYCLOSPORIN A; DOXYCYCLINE; ETHAMBUTOL; GANCICLOVIR; IMMUNOGLOBULIN; MEROPENEM; METHYLPREDNISOLONE; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; NYSTATIN; OFLOXACIN; PREDNISOLONE; RIFAMPICIN; STEROID; TACROLIMUS; THYMOCYTE ANTIBODY; TOBRAMYCIN; VALGANCICLOVIR; ANTIINFECTIVE AGENT;

ADULT; ANOREXIA; ARTICLE; ASPERGILLOSIS; BACTERIAL INFECTION; CASE REPORT; CHILD; CYSTIC FIBROSIS; CYTOMEGALOVIRUS INFECTION; DIABETES MELLITUS; DRUG BLOOD LEVEL; DRUG SUBSTITUTION; DRUG WITHDRAWAL; EMPYEMA; FEASIBILITY STUDY; FEMALE; FOLLOW UP; HEARING IMPAIRMENT; HEART LUNG TRANSPLANTATION; HUMAN; IMMUNOSUPPRESSIVE TREATMENT; KIDNEY FAILURE; LEUKOPENIA; LUNG GRAFT REJECTION; LUNG INFECTION; LUNG TRANSPLANTATION; MALE; MYCOBACTERIOSIS; MYCOBACTERIUM ABSCESSUS; NAUSEA; OBSERVATIONAL STUDY; PAIN; PANCREAS INSUFFICIENCY; PHAEOHYPHOMYCOSIS; PNEUMOCYSTOSIS; PSEUDOMONAS INFECTION; RETROSPECTIVE STUDY; SCHOOL CHILD; SKIN ABSCESS; SKIN INFECTION; STENOTROPHOMONAS MALTOPHILIA; SURGICAL DRAINAGE; SURGICAL INFECTION; SURGICAL RISK; COMPLICATION; CONVALESCENCE; FORCED EXPIRATORY VOLUME; MICROBIOLOGY; MULTIDRUG RESISTANCE; MYCOBACTERIUM INFECTIONS; YOUNG ADULT;

ADULT; ANTI-BACTERIAL AGENTS; CHILD; CYSTIC FIBROSIS; DRUG RESISTANCE, MULTIPLE, BACTERIAL; FEMALE; FORCED EXPIRATORY VOLUME; HUMANS; LUNG TRANSPLANTATION; MALE; MYCOBACTERIUM INFECTIONS; RECOVERY OF FUNCTION; TRANSPLANTATION CONDITIONING; YOUNG ADULT;

EID: 77953915302     PISSN: 15691993     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jcf.2010.03.008     Document Type: Article

References (16)

1. Levy I., Grisaru-Soen G., Lerner-Geva L., Kerem E., Blau H., Bentur L., et al. Multicenter cross-sectional study of nontuberculous mycobacterial infections among cystic fibrosis patients, Israel. Emerg Infect Dis Mar. 2008, 14(3):378-384.
2. Petrini B. Mycobacterium abscessus: an emerging rapid-growing potential pathogen. APMIS May 2006, 114(5):319-328.
3. Sanguinetti M., Ardito F., Fiscarelli E., La Sorda M., D'Argenio P., Ricciotti G., et al. Fatal pulmonary infection due to multidrug-resistant Mycobacterium abscessus in a patient with cystic fibrosis. J Clin Microbiol Feb. 2001, 39(2):816-819.
4. Taylor J.L., Palmer S.M. Mycobacterium abscessus chest wall and pulmonary infection in a cystic fibrosis lung transplant recipient. J Heart Lung Transplant Aug. 2006, 25(8):985-988.
5. Trulock E.P., Bolman R.M., Genton R. Pulmonary disease caused by Mycobacterium chelonae in a heart-lung transplant recipient with obliterative bronchiolitis. Am Rev Respir Dis Sep. 1989, 140(3):802-805.
6. Talati N.J., Rouphael N., Kuppalli K., Franco-Paredes C. Spectrum of CNS disease caused by rapidly growing mycobacteria. Lancet Infect Dis Jun. 2008, 8(6):390-398.
7. Malouf M.A., Glanville A.R. The spectrum of mycobacterial infection after lung transplantation. Am J Respir Crit Care Med Nov. 1999, 160(5 Pt 1):1611-1616.
8. Morales P., Ros J.A., Blanes M., Perez-Enguix D., Saiz V., Santos M. Successful recovery after disseminated infection due to mycobacterium abscessus in a lung transplant patient: subcutaneous nodule as first manifestation-a case report. Transplant Proc Sep. 2007, 39(7):2413-2415.
9. Chernenko S.M., Humar A., Hutcheon M., Chow C.W., Chaparro C., Keshavjee S., et al. Mycobacterium abscessus infections in lung transplant recipients: the international experience. J Heart Lung Transplant Dec. 2006, 25(12):1447-1455.
10. Chalermskulrat W., Sood N., Neuringer I.P., Hecker T.M., Chang L., Rivera M.P., et al. Non-tuberculous mycobacteria in end stage cystic fibrosis: implications for lung transplantation. Thorax Jun. 2006, 61(6):507-513.
11. Zaidi S., Elidemir O., Heinle J.S., McKenzie E.D., Schecter M.G., Kaplan S.L., et al. Mycobacterium abscessus in cystic fibrosis lung transplant recipients: report of 2 cases and risk for recurrence. Transpl Infect Dis Jun. 2009, 11(3):243-248.
12. Jonsson B.E., Gilljam M., Lindblad A., Ridell M., Wold A.E., Welinder-Olsson C. Molecular epidemiology of Mycobacterium abscessus, with focus on cystic fibrosis. J Clin Microbiol May 2007, 45(5):1497-1504.
13. Jordan P.W., Stanley T., Donnelly F.M., Elborn J.S., McClurg R.B., Millar B.C., et al. Atypical mycobacterial infection in patients with cystic fibrosis: update on clinical microbiology methods. Lett Appl Microbiol May 2007, 44(5):459-466.
14. Catherinot E., Roux A.L., Macheras E., Hubert D., Matmar M., Dannhoffer L., et al. Acute respiratory failure involving an R variant of Mycobacterium abscessus. J Clin Microbiol Jan. 2009, 47(1):271-274.
15. Haworth C., Bowden A., Elliot J., Barker H., Bilton D., Wat D., et al. Treatment of non-tuberculous mycobacteria in adults with cystic fibrosis. J Cyst Fibros 2009, 8:S46. [abstract].
16. Robertson J., Elidemir O., Saz E.U., Gulen F., Schecter M., McKenzie E., et al. Hypogammaglobulinemia: incidence, risk factors, and outcomes following pediatric lung transplantation. Pediatr Transplant Sep. 2009, 13(6):754-759.